UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000027432
Receipt number R000031396
Scientific Title Afatinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring active EGFR mutations : an open-label, randomized, multicenter, phase II study
Date of disclosure of the study information 2017/06/18
Last modified on 2019/06/06 11:49:03

No. Disposal Last modified on Item of update
1 Insert 2017/05/21 23:35:24
2 Update 2017/09/15 18:12:35 Recruitment status
3 Update 2019/06/06 11:49:03 Recruitment status
Date of IRB
Last follow-up date
Other related information